Coya Therapeutics, Inc.COYANASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-99.92%
↓ 103% below average
Average (18q)
3708.03%
Historical baseline
Range
High:70154.12%
Low:-99.92%
Volatility
1894.6%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -99.92% |
| Q2 2025 | 70154.12% |
| Q1 2025 | 169.12% |
| Q4 2024 | -12.88% |
| Q3 2024 | -51.30% |
| Q2 2024 | 44.35% |
| Q1 2024 | 75.46% |
| Q4 2023 | 13.23% |
| Q3 2023 | 12.29% |
| Q2 2023 | 15.12% |
| Q1 2023 | 12.17% |
| Q4 2022 | -22.31% |
| Q3 2022 | -2.35% |
| Q2 2022 | 47.87% |
| Q1 2022 | 14.37% |
| Q4 2021 | 8.97% |
| Q3 2021 | 74.34% |
| Q2 2021 | -0.00% |
| Q1 2021 | 0.00% |